<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01110655</url>
  </required_header>
  <id_info>
    <org_study_id>WSER 2009</org_study_id>
    <nct_id>NCT01110655</nct_id>
  </id_info>
  <brief_title>The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated Hyponatremia</brief_title>
  <official_title>Incidence and Cause of Hyponatremia in Endurance Runners, Also to Determine if Oral Hypertonic Saline is as Efficacious as Intravenous Hypertonic Saline in the Correction of Below Normal Blood Sodium Concentrations in Runners With Hyponatremia Without Neurological Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western States Endurance Run Research Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western States Endurance Run Research Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to 1) evaluate incidence and primary cause of exercise-associated
      Hyponatremia (EAH) in race finishers participating in the Western States 100-mile Endurance
      Run, 2) determine if the ingestion of oral hypertonic saline (high salt) is as effective as
      intravenous administration of hypertonic saline to elevate below-normal blood salt
      concentrations (EAH) at the end of the Western States Endurance Run, and 3) determine if oral
      and intravenous hypertonic saline solutions are equally as effective at reversing mild
      (without altered mental status) symptoms associated with EAH.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2009</start_date>
  <completion_date type="Anticipated">June 2010</completion_date>
  <primary_completion_date type="Anticipated">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood sodium concentration post administration of oral or IV hypertonic saline.</measure>
    <time_frame>1 hour post administration of hypertonic saline</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Exercise-associated Hyponatremia</condition>
  <arm_group>
    <arm_group_label>Intravenous hypertonic saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral hypertonic saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intravenous hypertonic Saline</intervention_name>
    <description>Intravenous 100mL bolus of 3% saline</description>
    <arm_group_label>Intravenous hypertonic saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral hypertonic saline</intervention_name>
    <description>Oral 100mL bolus of 3% saline</description>
    <arm_group_label>Oral hypertonic saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  consenting Western States 100 race finisher

          -  hyponatremic

        Exclusion Criteria:

          -  altered mental status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin D Hoffman, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Western States Endurance Run Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin D Hoffman, MD</last_name>
    <phone>(916) 843-9027</phone>
    <email>martin.hoffman@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bethan E Owen, BM</last_name>
    <email>bethanelin@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Western States Endurance Run</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95835</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin D Hofman, MD</last_name>
      <phone>916-843-9027</phone>
      <email>martin.hoffman@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Bethan E Owen, BM</last_name>
      <email>bethanelin@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Tamara Hew-Butler, DPM, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2010</study_first_submitted>
  <study_first_submitted_qc>April 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2010</study_first_posted>
  <last_update_submitted>April 23, 2010</last_update_submitted>
  <last_update_submitted_qc>April 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>Martin D. Hoffman, MD</name_title>
    <organization>Western States Endurance Run</organization>
  </responsible_party>
  <keyword>Exercise-associated hyponatremia</keyword>
  <keyword>Randomized treatment trial</keyword>
  <keyword>Endurance runners</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyponatremia</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>June 1, 2015</submitted>
    <returned>June 17, 2015</returned>
    <submitted>December 8, 2015</submitted>
    <returned>January 8, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

